文献
J-GLOBAL ID:201802228391241461
整理番号:18A0269865
多発性骨髄腫および他の形質細胞疾患の診断と管理における~18FDG PET/CTの役割:国際骨髄腫ワーキンググループによる合意声明【Powered by NICT】
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
著者 (28件):
Cavo Michele
(Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy)
,
Terpos Evangelos
(Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece)
,
Nanni Cristina
(Nuclear Medicine, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy)
,
Moreau Philippe
(Haematology Department, University Hospital of Nantes, Nantes, France)
,
Lentzsch Suzanne
(Columbia University Medical Center, New York, NY, USA)
,
Zweegman Sonja
(Department of Hematology, VU University Medical Center, Amsterdam, Netherlands)
,
Hillengass Jens
(Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany)
,
Engelhardt Monika
(Department of Medicine, Hematology, Oncology & Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
,
Usmani Saad Z
(Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA)
,
Vesole David H
(John Theurer Cancer Center at Hackensack UMC, Hackensack, NJ, USA)
,
San-Miguel Jesus
(Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain)
,
Kumar Shaji K
(Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA)
,
Richardson Paul G
(Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Mikhael Joseph R
(Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA)
,
da Costa Fernando Leal
(Myeloma Clinic, Hematology Department, Instituto Portugues de Oncologia Francisco Gentil, Lisboa, Portugal)
,
Dimopoulos Meletios-Athanassios
(Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece)
,
Zingaretti Chiara
(Biostatistics and Clinical trial Unit, IRST-IRCCS, Meldola, Italy)
,
Abildgaard Niels
(Department of Hematology, Odense University Hospital, Odense, Denmark)
,
Goldschmidt Hartmut
(Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany)
,
Orlowski Robert Z
(The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Chng Wee Joo
(National University Cancer Institute, National University Health System, Singapore)
,
Einsele Hermann
(Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany)
,
Lonial Sagar
(Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA)
,
Barlogie Bart
(Tisch Cancer Institute/Multiple Myeloma Program, Mt. Sinai Cancer Institute, New York, NY, USA)
,
Anderson Kenneth C
(Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA, USA)
,
Rajkumar S Vincent
(Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA)
,
Durie Brian G M
(Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA, USA)
,
Zamagni Elena
(Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
18
号:
4
ページ:
e206-e217
発行年:
2017年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)